2010
DOI: 10.3109/01480545.2010.482588
|View full text |Cite
|
Sign up to set email alerts
|

Acute intravenous injection toxicity of BMEDA in mice

Abstract: (188)Re/(186)Re-N,N-bis(2-mercaptoethyl)-N',N'-diethylethylenediamine-labeled pegylated liposome ((188)Re-BMEDA-liposome) has been proven as a promising candidate for cancer therapy in tumor-rodent models. (188)Re-BMEDA complexes should be prepared for the radiolabeling of liposomes. This article describes the acute toxicity of BMEDA in Imprinting Control Region (ICR) mice. Treated mice were administered with BMEDA at dose levels of 3, 6, 9, and 12 mg/kg, with a dose volume of 10 mL/kg. The control mice were a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…However, prior to the Investigational New Drug application, where an estimate of drug’s safety for initial human use should be performed, both animal pharmacology and toxicology studies for both the 188 Re-BMEDA-liposome as well as the BMEDA must be performed, since BMEDA is a particular ingredient in the 188 Re-BMEDA-liposome. Within a 14-day period, the extended acute toxicity of BMEDA had been evaluated in ICR mice where the No Observed Adverse Effect Level (NOAEL) of BMEDA for them was 3 mg/kg [21]. Likewise, the NOAEL of BMEDA in Beagle dogs was 1 mg/kg [22].…”
Section: Discussionmentioning
confidence: 99%
“…However, prior to the Investigational New Drug application, where an estimate of drug’s safety for initial human use should be performed, both animal pharmacology and toxicology studies for both the 188 Re-BMEDA-liposome as well as the BMEDA must be performed, since BMEDA is a particular ingredient in the 188 Re-BMEDA-liposome. Within a 14-day period, the extended acute toxicity of BMEDA had been evaluated in ICR mice where the No Observed Adverse Effect Level (NOAEL) of BMEDA for them was 3 mg/kg [21]. Likewise, the NOAEL of BMEDA in Beagle dogs was 1 mg/kg [22].…”
Section: Discussionmentioning
confidence: 99%
“…In our previous findings, 188 Re–BMEDA–liposome has been proved as a promising candidate for cancer therapy in C26 murine colon carcinoma ascites (Chang et al ., 2008; Chen et al ., 2007, 2008), solid tumor model (Chang et al ., 2007, 2008, 2010) and human colorectal solid tumor model (Chen et al ., 2010). In addition, an acute toxicity study of BMEDA in mice was also performed in our laboratory (Chang et al ., in press). Because the radiotoxicological data of 188 Re–BMEDA–liposome were limited, a toxicity test of 188 Re–BMEDA–liposome in Sprague–Dawley rats was performed in this study.…”
Section: Discussionmentioning
confidence: 99%